Oruka Therapeutics, Inc.
ORKANASDAQ🇺🇸Healthcare · Biotechnology
Last updated: 16h ago
52-Week Range
Company Overview
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in
Valuation
Profitability
Growth & Stability
Dividends
Trading Info
Related News
Oruka Therapeutics, Inc. Chief Medical Officer sells $313K in company stock
🔴 Sale Goncalves Joana (Chief Medical Officer) sold 7,641 shares of Oruka Therapeutics, Inc. (ORKA) at $40.91/share. Total: $313K. (SEC Form 4 Filing)
[StockHub Brief] Mar 16 US Market Opens Mixed Amid Tech Strength
📊 Market Summary The US market opened on a positive note on March 16, 2026, with technology stocks leading the gains. The S&P 500 rose 1.04% to 6,700.88, the Nasdaq climbed 1.21% to 22,373.57, and the Dow Jones Industrial Average was up 0.9% at 46,976.57. 📌 Key Stocks (No data available) 📈 Top Gainers Oruka Therapeutics (ORKA) surged 25.04%, attracting significant attention. United States Antimony Corporat (UAMY) and Akso Health Group (AHG) also saw strong gains of 15.62% and 14.68%, respectively. 📉 Top Losers EverCommerce Inc. (EVCM) experienced a sharp decline of 16.6%, while Ulta Beauty, Inc. (ULTA) and IperionX Limited (IPX) fell 14.24% and 14.03%, respectively. 👥 Investor Flow (No data available) 💱 FX & Commodities The USD/KRW exchange rate decreased by 0.51% to 1,489.9. WTI crude oil prices dropped 3.78% to $94.98, and gold prices fell 1.11% to $5,005.50. ₿ Crypto Bitcoin was trading up 0.69% at $73,325.24, and Ethereum saw a significant jump of 4.17% to $2,269.38. 💬 Comment The market showed a mixed sentiment with tech strength contrasting with falling commodities, highlighting individual stock performance.
[StockHub Brief] US Stocks Close Higher Led by Tech Gains
📊 Market Summary US stocks closed higher across the board, led by strong performance in technology shares. The S&P 500 rose 1.01%, the Nasdaq climbed 1.22%, and the Dow Jones Industrial Average gained 0.83%. 📈 Top Gainers Oruka Therapeutics (ORKA) surged 25.04%, leading the market, with United States Antimony Corporat (UAMY) and Akso Health Group (AHG) also posting double-digit gains. 📉 Top Losers Conversely, Ulta Beauty, Inc. (ULTA) plunged 14.24%, marking the day's biggest decliner, while IperionX Limited (IPX) and 10x Genomics, Inc. (TXG) also experienced significant drops. 💱 FX & Commodities The Korean Won weakened against the US Dollar, closing down 0.52% at 1,489.8 KRW/USD. WTI crude oil prices fell sharply by 4.98% to $93.79 per barrel, and gold prices also declined by 0.84%. ₿ Crypto Bitcoin saw a 1.48% increase, trading at $73,896.53, while Ethereum experienced a significant jump of 6.69% to $2,324.16. 💬 Comment A day of improved investor sentiment as major indices advanced, fueled by a rally in tech stocks.
